Patients with metastatic cancer who are treated with an anti-programmed death therapy are at an increased risk for neurological complications. READ MORE
Research in Review
When chemotherapy alone is used to treat cancer, some dormant cells may survive and become resistant to additional treatment; but, when combined with immunotherapy, the majority of these cells may be destroyed, according to recent data.
Treatment with two immunotherapeutic agents for cancer may cause patients to develop arthritis.
A long-term clinical trial of suicide gene therapy has shown that it safely and effectively destroys prostate cancer cells.
A new immunotherapy may help to improve outcomes of patients with metastatic bladder cancer, according to the results of a Phase II study.